Nocturnal hypoglycemia in type 1 and type 2 diabetes: an update on prevalence, prevention, pathophysiology and patient awareness

References

• Raju B, Arbelaez AM, Breckenridge SM, et al. Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments. J Clin Endocrinol Metab. 2006;91(6):2087–2092.
   PubMed Web of Science ®Google Scholar
• Ertl AC, Davis SN. Evidence for a vicious cycle of exercise and hypoglycemia in type 1 diabetes mellitus. Diabetes Metab Res Rev. 2004;20(2):124–130.
   PubMed Web of Science ®Google Scholar
• Allen KV, Frier BM. Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. Endocr Pract. 2003;9(6):530–543.
   PubMedGoogle Scholar
• Kalsbeek A, La Fleur S, Fliers E. Circadian control of glucose metabolism. Mol Metab. 2014;3(4):372–383.
   PubMed Web of Science ®Google Scholar
• Davis SN, Mann S, Briscoe VJ, et al. Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes. Diabetes. 2009;58(3):701–709.
   Web of Science ®Google Scholar
• Sprague JE, Arbeláez AM. Glucose counterregulatory responses to hypoglycemia. Vol. 9, Pediatric Endocrinology Reviews. 2011.
   Google Scholar
• Galassetti P, Tate D, Neill RA, et al. Effect of antecedent hypoglycemia on counterregulatory responses to subsequent euglycemic exercise in type 1 diabetes. Diabetes. 2003;52(7):1761–1769.
   PubMed Web of Science ®Google Scholar
• The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med. 1991;90(4):450–459.
   Web of Science ®Google Scholar
• Amin R, Ross K, Acerini CI, et al. Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabetes Care. 2003;26(3):662–667.
   Web of Science ®Google Scholar
• Khunti K, Alsifri S, Aronson R, et al. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab. 2016;18(9):907–915.
   Web of Science ®Google Scholar
• Ahmet A, Dagenais S, Barrowman NJ, et al. Prevalence of nocturnal hypoglycemia in pediatric type 1 diabetes: a pilot study using continuous glucose monitoring. J Pediatr. 2011;159(2):297–302.e1.
   PubMed Web of Science ®Google Scholar
• Cariou B, Fontaine P, Eschwege E, et al. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study. Diabetes Metab. 2015;41(2):116–125.
   Web of Science ®Google Scholar
• Aronson R, Goldenberg R, Boras D, et al. The Canadian hypoglycemia assessment tool program: insights into rates and implications of hypoglycemia from an observational study. Can J Diabetes. 2018;42(1):11–17.
   PubMed Web of Science ®Google Scholar
• Vu L, Kefayati S, Idé T, et al. Predicting nocturnal hypoglycemia from continuous glucose monitoring data with extended prediction horizon. AMIA. Annu Symp proceedings AMIA Symp. 2019;2019.
   Google Scholar
• Guzmán G, Martínez V, Yara JD, et al. Glycemic control and hypoglycemia in patients treated with insulin pump therapy: an observational study. J Diabetes Res. 2020;2020:1581726.
   PubMed Web of Science ®Google Scholar
• Leiter LA, Boras D, Woo VC. Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals. Can J Diabetes. 2014;38(1):38–44.
   PubMed Web of Science ®Google Scholar
• Brod M, Wolden M, Christensen T, et al. Understanding the economic burden of nonsevere nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization. Value Heal. 2013;16(8):1140–1149.
   PubMed Web of Science ®Google Scholar
• Östenson CG, Geelhoed-Duijvestijn P, Lahtela J, et al. Self-reported non-severe hypoglycaemic events in Europe. Diabet Med. 2014;31(1):92–101.
   PubMed Web of Science ®Google Scholar
• Gill GV, Woodward A, Casson IF, et al. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes-the “dead in bed” syndrome revisited. Diabetologia. 2009;52(1):42–45.
   Web of Science ®Google Scholar
• Pazos-Couselo M, García-López JM, González-Rodríguez M, et al. High incidence of hypoglycemia in stable insulin-treated Type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose. Observational prospective study. Can J Diabetes. 2015;39(5):428–433.
   PubMed Web of Science ®Google Scholar
• Wilson DM, Calhoun PM, Maahs DM, et al. Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes. Diabetes Technol Ther. 2015;17(6):385–391.
   PubMed Web of Science ®Google Scholar
• McAuley SA, Vogrin S, Lee MH, et al. Less nocturnal hypoglycemia but equivalent time in range among adults with Type 1 diabetes using insulin pumps versus multiple daily injections. Diabetes Technol Ther [Internet]. 2021 Jan 27;dia.2020.0589. [cited 2021 Jul 27]. Available from:
   Google Scholar
• Ratzki-Leewing A, Harris SB, Mequanint S, et al. Real-world crude incidence of hypoglycemia in adults with diabetes: results of the InHypo-DM study, Canada. BMJ Open Diabetes Res Care. 2018;6(1):e000503.
   PubMed Web of Science ®Google Scholar
• Pieber TR, Eugène-Jolchine I, Derobert E. Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. Diabetes Care. 2000;23(2):157–162.
   PubMed Web of Science ®Google Scholar
• Ratner RE, Hirsch IB, Neifing JL, et al. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. study group of insulin glargine in Type 1 diabetes. Diabetes Care. 2000;23(5):639–643.
   Web of Science ®Google Scholar
• Robertson KJ, Schoenle E, Gucev Z, et al. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes. Diabet Med. 2007;24(1):27–34.
   Web of Science ®Google Scholar
• Pan C, Gross JL, Yang W, et al. A multinational, randomized, open-label, treat-to-target trial comparing insulin degludec and insulin glargine in insulin-Naïve patients with Type 2 diabetes mellitus. Drugs R D. 2016;16(2):239–249.
   PubMed Web of Science ®Google Scholar
• Kumar S, Jang HC, Demirağ NG, et al. Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study. Diabet Med. 2017;34(2):180–188.
   Web of Science ®Google Scholar
• Wysham C, Bhargava A, Chaykin L, et al. Effect of insulin degludec vs insulin glargine U100 on hypoglycemia in patients with type 2 diabetes the SWITCH 2 randomized clinical trial. J Am Med Assoc. 2017;318(1):45.
   Google Scholar
• Yki-Järvinen H, Dressler A, Ziemen M. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care. 2000;23(8):1130–1136.
   Web of Science ®Google Scholar
• Rosenstock J, Schwartz SL, Clark CM, et al. Basal insulin therapy in type 2 diabetes: 28-Week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care. 2001;24(4):631–636.
   Web of Science ®Google Scholar
• Riddle M, Rosenstock J, Gerich J. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26(11):3080–3086.
   PubMed Web of Science ®Google Scholar
• Fritsche A, Schweitzer MA, Häring HU. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with Type 2 diabetes: a randomized, controlled trial. Ann Intern Med. 2003;138(12):952.
   PubMed Web of Science ®Google Scholar
• Standl E, Lang H, Roberts A. The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetes. Diabetes Technol Ther. 2004;6(5):579–588.
   Google Scholar
• Bartley PC, Bogoev M, Larsen J, et al. Long-term efficacy and safety of insulin detemir compared to neutral protamine hagedorn insulin in patients with type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial. Diabet Med. 2008;25(4):442–449.
   PubMed Web of Science ®Google Scholar
• Kølendorf K, Ross GP, Pavlic-Renar I, et al. Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes. Diabet Med. 2006;23(7):729–735.
   PubMed Web of Science ®Google Scholar
• Pieber TR, Draeger E, Kristensen A, et al. Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin. Diabet Med. 2005;22(7):850–857.
   Web of Science ®Google Scholar
• Szypowska A, Golicki D, Groele L, et al. Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes: a systematic review and meta-analysis. Pol Arch Med Wewn. 2011;121(7–8):237–246.
   PubMed Web of Science ®Google Scholar
• Rosenstock J, Dailey G, Massi-Benedetti M, et al. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care. 2005;28(4):950–955.
   Web of Science ®Google Scholar
• Zhang X-W, Zhang X-L, Xu B, et al. Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials. Acta Diabetol. 2018;55(5):429–441.
   Web of Science ®Google Scholar
• Benkhadra K, Alahdab F, Tamhane SU, et al. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis. Endocrine. 2017;55(1):77–84.
   PubMed Web of Science ®Google Scholar
• Graveling AJ, Frier BM. The risks of nocturnal hypoglycaemia in insulin-treated diabetes. Diabetes Res Clin Pract. 2017 Nov;133:30–39.
   PubMed Web of Science ®Google Scholar
• Frier BM. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. Nat Rev Endocrinol. 2014 Dec;10(12):711–722.
   PubMed Web of Science ®Google Scholar
• Jones TW, Porter P, Sherwin RS, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med. 1998 Jun;338(23):1657–1662.
   PubMed Web of Science ®Google Scholar
• Chow E, Bernjak A, Williams S, et al. Risk of cardiac arrhythmias during hypoglycemia in patients with Type 2 diabetes and cardiovascular risk. Diabetes. 2014 May;63(5):1738–1747.
   PubMed Web of Science ®Google Scholar
• Fisher BM, Frier BM. Nocturnal convulsions and insulin-induced hypoglycaemia in diabetic patients. Postgrad Med J. 1987 Aug;63(742):673–676.
   PubMed Web of Science ®Google Scholar
• Frier BM, Jensen MM, Chubb BD. Hypoglycaemia in adults with insulin‐treated diabetes in the UK : self‐reported frequency and effects. Diabet Med. 2016 Aug;33(8):1125–1132.
   PubMed Web of Science ®Google Scholar
• Brod M, Wolden M, Christensen T, et al. A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes Obes Metab. 2013;15(6):546–557.
   PubMed Web of Science ®Google Scholar
• MacDonald MJ. Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care. 1987 Sep;10(5):584–588.
   PubMed Web of Science ®Google Scholar
• Bae JP, Duan R, Fu H, et al. Risk factors for nocturnal hypoglycemia in insulin-treated patients with Type 2 diabetes: a secondary analysis of observational data derived from an integrated clinical trial database. Clin Ther. 2017;39(9):1790–1798.e7.
   Web of Science ®Google Scholar
• Middleton TL, Wong J, Molyneaux L, et al. Cardiac effects of Sulfonylurea-related hypoglycemia. Diabetes Care [Internet]. 2017 May;40(5):663–670. Available from]. ;():
   PubMed Web of Science ®Google Scholar
• Cooperberg BA, Breckenridge SM, Arbelaez AM, et al. Terbutaline and the prevention of nocturnal hypoglycemia in type 1 diabetes. Diabetes Care. 2008;31(12):2271–2272.
   PubMed Web of Science ®Google Scholar
• Turner BC, Jenkins E, Kerr D, et al. The effect of evening alcohol consumption on next-morning glucose control in Type 1 diabetes. Diabetes Care [Internet]. 2001 Nov 1;24(11):1888–1893.
   PubMed Web of Science ®Google Scholar
• Tetzschner R, Nørgaard K, Ranjan A. Effects of alcohol on plasma glucose and prevention of alcohol-induced hypoglycemia in type 1 diabetes-A systematic review with GRADE. Diabetes Metab Res Rev. 2018 Mar;34(3):e2965.
   Web of Science ®Google Scholar
• Maran A, Pavan P, Bonsembiante B, et al. Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetes. Diabetes Technol Ther. 2010;12(10):763–768.
   PubMed Web of Science ®Google Scholar
• Gomez AM, Gomez C, Aschner P, et al. Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy. J Diabetes Sci Technol. 2015;9(3):619–624.
   PubMedGoogle Scholar
• Zaharieva DP, Cinar A, Yavelberg L, et al. No disadvantage to insulin pump off vs pump on during intermittent high-intensity exercise in adults with Type 1 diabetes. Can J Diabetes. 2020;44(2):162–168.
   Web of Science ®Google Scholar
• Ólafsdóttir AF, Polonsky W, Bolinder J, et al. A randomized clinical trial of the effect of continuous glucose monitoring on nocturnal hypoglycemia, daytime hypoglycemia, glycemic variability, and hypoglycemia confidence in persons with Type 1 diabetes treated with multiple daily insulin injections (GOLD-3). Diabetes Technol Ther. 2018;20(4):274–284.
   PubMed Web of Science ®Google Scholar
• Little S, Shaw J, Home P. Hypoglycemia rates with basal insulin analogs. Diabetes Technol Ther. 2011;13(S1):S-53-S-64.
   PubMedGoogle Scholar
• Hamann A, Matthaei S, Rosak C, et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care. 2003;26(6):1738–1744.
   PubMed Web of Science ®Google Scholar
• Davis T, Salahi A, Welsh JB, et al. Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications. Diabetes Obesity Metab. 2015;17(12):1126–1132.
   Web of Science ®Google Scholar
• Steineck I, Ranjan A, Nørgaard K, et al. Sensor-augmented insulin pumps and hypoglycemia prevention in Type 1 diabetes. J Diabetes Sci Technol. 2017;11(1):50–58.
   PubMedGoogle Scholar
• Chen E, King F, Kohn MA, et al. A review of predictive low glucose suspend and its effectiveness in preventing nocturnal hypoglycemia. Diabetes Technol Ther. 2019;21(10):602–609.
   PubMed Web of Science ®Google Scholar
• Tauschmann M, Thabit H, Bally L, et al. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet. 2018;392(10155):1321–1329.
   PubMed Web of Science ®Google Scholar
• Brown SA, Kovatchev BP, Raghinaru D, et al. Six-month randomized, multicenter trial of closed-loop control in Type 1 diabetes. N Engl J Med. 2019;381(18):1707–1717.
   Web of Science ®Google Scholar
• Abitbol A, Rabasa-Lhoret R, Messier V, et al. Overnight glucose control with dual- and single-hormone artificial pancreas in Type 1 diabetes with hypoglycemia unawareness: a randomized controlled trial. Diabetes Technol Ther. 2018;20(3):189–196.
   PubMed Web of Science ®Google Scholar
• Haidar A, Legault L, Messier V, et al. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Lancet Diabetes Endocrinol. 2015;3(1):17–26.
   Web of Science ®Google Scholar
• Haidar A, Rabasa-Lhoret R, Legault L, et al. Single- and dual-hormone artificial pancreas for overnight glucose control in type 1 diabetes. J Clin Endocrinol Metab. 2016;101(1):214–223.
   PubMed Web of Science ®Google Scholar
• Castle JR, Youssef J, Wilson LM, et al. Randomized outpatient trial of single- and dual-hormone closed-loop systems that adapt to exercise using wearable sensors. Diabetes Care. 2018;41(7):1471–1477.
   Web of Science ®Google Scholar
• Cryer P, Longo DL. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2013;369(4):362–372.
   PubMed Web of Science ®Google Scholar
• Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American diabetes association and the endocrine society. Diabetes Care. 2013 May 1;36(5):1384–1395.
   PubMed Web of Science ®Google Scholar
• Cryer P. Hypoglycemia in diabetes: pathophysiology, prevalence, and prevention. 2nd ed. USA: Am Diabetes Assoc; 2012.
   Google Scholar
• Cryer P, Davis S, Shamoon H. Hypoglycemia in Diabetes. Diabetes Care. 2003 Jun;26(6):1902–1912.
   PubMed Web of Science ®Google Scholar
• Davis S, Mosqueda-Garcia R, Costa F. Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes. 1997;46(8):1328–1335.
   PubMed Web of Science ®Google Scholar
• Gold A, Macleod K, Frier B. Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17(7):697–703.
   PubMed Web of Science ®Google Scholar
• Jauch-Chara K, Hallschmid M, Gais S, et al. Awakening and counterregulatory response to hypoglycemia during early and late sleep. Diabetes. 2007 Jul 1;56(7):1938–1942.
   PubMed Web of Science ®Google Scholar
• Banarer S, Cryer P. Sleep-related hypoglycemia-associated autonomic failure in Type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes. 2003;52:1195–1203.
   PubMed Web of Science ®Google Scholar
• Schultes B, Jauch-Chara K, Gais S, et al. Defective awakening response to nocturnal hypoglycemia in patients with Type 1 diabetes mellitus. PLoS Med. 2007 Feb 27;4(2):e69.
   PubMed Web of Science ®Google Scholar
• Abdelhamid Y, Bernjak A, Phillips LK, et al. Nocturnal hypoglycemia in patients with diabetes discharged from ICUs: a prospective two-center cohort study. Crit Care Med. 2021;49(4):636–649.
   PubMed Web of Science ®Google Scholar
• van Meijel LA, de Vegt F, Abbink EJ, et al. High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: the dutch diabetes pearl cohort. BMJ Open Diabetes Res Care. 2020 Feb 26;8(1):e000935.
   PubMed Web of Science ®Google Scholar
• Fritsche A, Stefan N, Häring H, et al. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing β-adrenergic sensitivity in Type 1 diabetes. Ann Intern Med. 2001 May 1;134(9_Part_1):729.
   PubMed Web of Science ®Google Scholar
• Yeoh E, Choudhary P, Nwokolo M, et al. Interventions that restore awareness of hypoglycemia in adults with Type 1 diabetes: a systematic review and meta-analysis. Diabetes Care. 2015 Aug;38(8):1592–1609.
   PubMed Web of Science ®Google Scholar
• Farrell CM, McCrimmon RJ. Clinical approaches to treat impaired awareness of hypoglycaemia. Ther Adv Endocrinol Metab. 2021 Jan 15;12:20420188211000248. doi: https://doi.org/10.1177/20420188211000248. PMID: 33796253; PMCID: PMC7968015.
   Google Scholar
• Cox D, Gonder-Frederick L, Polonsky W, et al. Blood glucose awareness training: what is it, where is it, and where is it going? Diabetes Spectr. 2006 Jan;19(1):43–49.
   Google Scholar
• Study Group D. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ.2002 Oct 5;325(7367):746.
   Google Scholar
• Hopkins D, Lawrence I, Mansell P, et al. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with Type 1 diabetes: the U.K. DAFNE experience. Diabetes Care. 2012 Aug 1;35(8):1638–1642.
   PubMed Web of Science ®Google Scholar
• Little SA, Leelarathna L, Walkinshaw E, et al. Recovery of hypoglycemia awareness in long-standing Type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care. 2014 Aug;37(8):2114–2122.
   Web of Science ®Google Scholar
• Little SA, Speight J, Leelarathna L, et al. Sustained reduction in severe hypoglycemia in adults with Type 1 diabetes complicated by impaired awareness of hypoglycemia: 2-year follow-up in the HypoCOMPaSS randomized clinical trial. Diabetes Care. 2018 Apr 16:dc172682. doihttps://doi.org/10.2337/dc17-2682.
   Google Scholar
• Cox DJ, Kovatchev B, Kovatchev B, et al. Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Int J Behav Med. 2004 Dec;11(4):212–218.
   PubMed Web of Science ®Google Scholar
• Hermanns N, Kulzer B, Krichbaum M, et al. Long-term effect of an education program (HyPOS) on the incidence of severe hypoglycemia in patients with Type 1 diabetes. Diabetes Care. 2010 Mar 1;33(3):e36–e36.
   PubMedGoogle Scholar
• De Zoysa N, Rogers H, Stadler M, et al. A psychoeducational program to restore hypoglycemia awareness: the DAFNE-HART pilot study: Table 1. Diabetes Care. 2014 Mar;37(3):863–866.
   Web of Science ®Google Scholar
• Choudhary P, Rickels MR, Senior PA, et al. Evidence-informed clinical practice recommendations for treatment of Type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care. 2015 Jun 21;38(6):1016–1029.
   Web of Science ®Google Scholar
• Brunton SA. Nocturnal hypoglycemia: answering the challenge with long-acting insulin analogs. Vol. 9, MedGenMed Medscape General Medicine. 2007.
   Google Scholar
• Home P, Bartley P, Russell-Jones D, et al. Insulin detemir offers improved glycemic control compared with NPH insulin in people with Type 1 diabetes: a randomized clinical trial. Diabetes Care. 2004;27(5):1081–1087.
   PubMed Web of Science ®Google Scholar
• Ashwell SG, Gebbie J, Home PD. Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times. Diabet Med. 2006;23(1):1464–1491.
   Web of Science ®Google Scholar
• Othonos N, Choudhary P. Who should be considered for islet transplantation alone? Vol. 17, Current Diabetes Reports. 2017.
   Google Scholar